These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24916714)

  • 1. Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.
    Jing F; Zhang J
    Dig Dis Sci; 2014 Nov; 59(11):2642-8. PubMed ID: 24916714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
    Tonini M; Pace F
    Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.
    Crowell MD; Shetzline MA; Moses PL; Mawe GM; Talley NJ
    Curr Opin Investig Drugs; 2004 Jan; 5(1):55-60. PubMed ID: 14983974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serotonin in gastrointestinal motility and irritable bowel syndrome.
    Sikander A; Rana SV; Prasad KK
    Clin Chim Acta; 2009 May; 403(1-2):47-55. PubMed ID: 19361459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model.
    Sghendo L; Mifsud J
    J Pharm Pharmacol; 2012 Mar; 64(3):317-25. PubMed ID: 22309263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression.
    Israelyan N; Del Colle A; Li Z; Park Y; Xing A; Jacobsen JPR; Luna RA; Jensen DD; Madra M; Saurman V; Rahim R; Latorre R; Law K; Carson W; Bunnett NW; Caron MG; Margolis KG
    Gastroenterology; 2019 Aug; 157(2):507-521.e4. PubMed ID: 31071306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract.
    Gershon MD
    Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):14-21. PubMed ID: 23222853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine and the gastrointestinal tract: where next?
    Sanger GJ
    Trends Pharmacol Sci; 2008 Sep; 29(9):465-71. PubMed ID: 19086255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies.
    Warden SJ; Haney EM
    J Musculoskelet Neuronal Interact; 2008; 8(2):121-32. PubMed ID: 18622081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-hydroxytryptamine-mediated neurotransmission modulates spontaneous and vagal-evoked glutamate release in the nucleus of the solitary tract effect of uptake blockade.
    Hosford PS; Mifflin SW; Ramage AG
    J Pharmacol Exp Ther; 2014 May; 349(2):288-96. PubMed ID: 24618127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ever-changing roles of serotonin.
    Jones LA; Sun EW; Martin AM; Keating DJ
    Int J Biochem Cell Biol; 2020 Aug; 125():105776. PubMed ID: 32479926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy.
    Guzel T; Mirowska-Guzel D
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLUOXETINE modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc.
    Di Lieto A; Leo D; Volpicelli F; di Porzio U; Colucci-D'Amato L
    Brain Res; 2007 Apr; 1143():1-10. PubMed ID: 17321503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors.
    Serafeim A; Grafton G; Chamba A; Gregory CD; Blakely RD; Bowery NG; Barnes NM; Gordon J
    Blood; 2002 Apr; 99(7):2545-53. PubMed ID: 11895792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin and the GI tract.
    Hasler WL
    Curr Gastroenterol Rep; 2009 Oct; 11(5):383-91. PubMed ID: 19765366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.